Latent infection of myeloid progenitors by human cytomegalovirus protects cells from FAS-mediated apoptosis through the cellular IL-10/PEA-15 pathway

References

1. Albright E.R., Kalejta R.F. 2013; Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34⁺ cell populations. J Virol 87:9802–9812 [View Article][PubMed]
   [Google Scholar]
2. Amsler L., Verweij M.C., DeFilippis V.R. 2013; The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. J Mol Biol 425:4857–4871 [View Article][PubMed]
   [Google Scholar]
3. Avdic S., Cao J.Z., Cheung A.K., Abendroth A., Slobedman B. 2011; Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation. J Virol 85:7465–7471 [View Article][PubMed]
   [Google Scholar]
4. Chan G., Nogalski M.T., Bentz G.L., Smith M.S., Parmater A., Yurochko A.D. 2010; PI3K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes. J Immunol 184:3213–3222 [View Article][PubMed]
   [Google Scholar]
5. Fu M., Gao Y., Zhou Q., Zhang Q., Peng Y., Tian K., Wang J., Zheng X. 2014; Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA. Gene 536:272–278 [View Article][PubMed]
   [Google Scholar]
6. Goodrum F.D., Jordan C.T., High K., Shenk T. 2002; Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci U S A 99:16255–16260 [View Article][PubMed]
   [Google Scholar]
7. Jackson S.E., Mason G.M., Wills M.R. 2011; Human cytomegalovirus immunity and immune evasion. Virus Res 157:151–160 [View Article][PubMed]
   [Google Scholar]
8. Keyes L.R., Hargett D., Soland M., Bego M.G., Rossetto C.C., Almeida-Porada G., St Jeor S. 2012; HCMV protein LUNA is required for viral reactivation from latently infected primary CD14⁺ cells. PLoS One 7:e52827 [View Article][PubMed]
   [Google Scholar]
9. Mason G.M., Poole E., Sissons J.G., Wills M.R., Sinclair J.H. 2012; Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4⁺ T-cell migration and suppression of effector function. Proc Natl Acad Sci U S A 109:14538–14543 [View Article][PubMed]
   [Google Scholar]
10. Mason G.M., Jackson S., Okecha G., Poole E., Sissons J.G., Sinclair J., Wills M.R. 2013; Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells. PLoS Pathog 9:e1003635 [View Article][PubMed]
    [Google Scholar]
11. McSharry B.P., Avdic S., Slobedman B. 2012; Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation. Viruses 4:2448–2470 [View Article][PubMed]
    [Google Scholar]
12. Noriega V., Redmann V., Gardner T., Tortorella D. 2012; Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 54:140–151 [View Article][PubMed]
    [Google Scholar]
13. Noriega V.M., Haye K.K., Kraus T.A., Kowalsky S.R., Ge Y., Moran T.M., Tortorella D. 2014; Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro. J Virol 88:9391–9405 [View Article][PubMed]
    [Google Scholar]
14. O'Connor C.M., Murphy E.A. 2012; A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny. J Virol 86:9854–9865 [View Article][PubMed]
    [Google Scholar]
15. Poole E., McGregor Dallas S.R., Colston J., Joseph R.S., Sinclair J. 2011; Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34⁺ progenitors. J Gen Virol 92:1539–1549 [View Article][PubMed]
    [Google Scholar]
16. Poole E., Walther A., Raven K., Benedict C.A., Mason G.M., Sinclair J. 2013; The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner. J Virol 87:4261–4271 [View Article][PubMed]
    [Google Scholar]
17. Poole E., Avdic S., Hodkinson J., Jackson S., Wills M., Slobedman B., Sinclair J. 2014a; Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 secretion during latent infection through changes in the cellular microRNA hsa-miR-92a. J Virol 88:13947–13955 [View Article][PubMed]
    [Google Scholar]
18. Poole E., Reeves M., Sinclair J.H. 2014b; The use of primary human cells (fibroblasts, monocytes, and others) to assess human cytomegalovirus function. Methods Mol Biol 1119:81–98 [View Article][PubMed]
    [Google Scholar]
19. Reeves M.B., Sinclair J.H. 2010; Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J Gen Virol 91:599–604 [View Article][PubMed]
    [Google Scholar]
20. Reeves M.B., MacAry P.A., Lehner P.J., Sissons J.G., Sinclair J.H. 2005; Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 102:4140–4145 [View Article][PubMed]
    [Google Scholar]
21. Reeves M.B., Breidenstein A., Compton T. 2012; Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells. Proc Natl Acad Sci U S A 109:588–593 [View Article][PubMed]
    [Google Scholar]
22. Rossetto C.C., Tarrant-Elorza M., Pari G.S. 2013; Cis trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells. PLoS Pathog 9:e1003366 [View Article][PubMed]
    [Google Scholar]
23. Slobedman B., Mocarski E.S. 1999; Quantitative analysis of latent human cytomegalovirus. J Virol 73:4806–4812[PubMed]
    [Google Scholar]
24. Todaro M., Zerilli M., Ricci-Vitiani L., Bini M., Perez Alea M., Maria Florena A., Miceli L., Condorelli G., Bonventre S., other authors. 2006; Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res 66:1491–1499 [View Article][PubMed]
    [Google Scholar]
25. Weber-Nordt R.M., Henschler R., Schott E., Wehinger J., Behringer D., Mertelsmann R., Finke J. 1996; Interleukin-10 increases Bcl-2 expression and survival in primary human CD34⁺ hematopoietic progenitor cells. Blood 88:2549–2558[PubMed]
    [Google Scholar]
26. Weekes M.P., Tan S.Y., Poole E., Talbot S., Antrobus R., Smith D.L., Montag C., Gygi S.P., Sinclair J.H., Lehner P.J. 2013; Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection. Science 340:199–202 [View Article][PubMed]
    [Google Scholar]
27. Weekes M.P., Tomasec P., Huttlin E.L., Fielding C.A., Nusinow D., Stanton R.J., Wang E.C., Aicheler R., Murrell I., other authors. 2014; Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell 157:1460–1472 [View Article][PubMed]
    [Google Scholar]